Efficacy of probiotics in treating liver cirrhosis: a meta analysis

Chinese Journal of Gastroenterology

Volumn 19, Issue 1, 2014, Pages 25-31

  Zhang, Mingming ^a,c   Fang, Tian ^b   Zhang, Jing ^a   Yu, Chenggong ^c  

^a FUDAN UNIVERSITY   (China)

^b WOMEN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Liver cirrhosis; Meta analysis; Probiotics

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; AMMONIA; ASPARTATE AMINOTRANSFERASE; ENDOTOXIN; PROBIOTIC AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL PERITONITIS; COMPUTER PROGRAM; DRUG EFFICACY; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR;

EID: 84895803635     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1008-7125.2014.01.006     Document Type: Article

References (30)

1. Guerrero Hernández I, Torre Delgadillo A, Vargas Vorackova F, et al. Intestinal flora, probiotics, and cirrhosis[J]. Ann Hepatol, 2008, 7 (2): 120-124.
2. Bajaj J S, Saeian K, Christensen K M, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy[J]. Am J Gastroenterol, 2008, 103 (7): 1707-1715.
3. Liu Q, Duan Z P, Ha D K, et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis[J]. Hepatology, 2004, 39 (5): 1441-1449.
4. Malaguarnera M, Gargante M P, Malaguarnera G, et al. Bifidobacterium combined with fructo-oligosaccharide versus lactulose in the treatment of patients with hepatic encephalopathy[J]. Eur J Gastroenterol Hepatol, 2010, 22 (2): 199-206.
5. Mittal V V, Sharma B C, Sharma P, et al. A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy[J]. Eur J Gastroenterol Hepatol, 2011, 23 (8): 725-732.
6. Pande C, Kumar A, Sarin S K. Addition of probiotics to norfloxacin does not improve efficacy in the prevention of spontaneous bacterial peritonitis: a double-blind placebo-controlled randomized-controlled trial[J]. Eur J Gastroenterol Hepatol, 2012, 24 (7): 831-839.
7. Pereg D, Kotliroff A, Gadoth N, et al. Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study[J]. Nutrition, 2011, 27 (2): 177-181.
8. Saji S, Kumar S, Thomas V. A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy[J]. Trop Gastroenterol, 2011, 32 (2): 128-132.
9. Sharma P, Sharma B C, Puri V, et al. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy[J]. Eur J Gastroenterol Hepatol, 2008, 20 (6): 506-511.
10. Zhao H Y, Wang H J, Lu Z, et al. Intestinal microflora in patients with liver cirrhosis[J]. Chin J Dig Dis, 2004, 5 (2): 64-67.
11. 2010, 7 (23): 27-28.
12. 2009, 22 (3): 296-297.
13. 2006, 18 (3): 245-246.
14. 2008.
15. 2011, 14 (4): 292-294.
16. 2004, 13 (2): 150.
17. 2010, 19 (8): 746-748.
18. 2009, 8 (9): 81, 84.
19. 2009, 11 (18): 62.
20. 2009, 9 (3): 576-577.
21. 2011, 8 (22): 75-76.
22. 2011, 11 (9): 1056-1057.
23. 2009, 17 (36): 3745-3748.
24. 2012, 24 (1): 49-51.
25. 2011, 11 (11): 1314-1315.
26. 2008, 20 (3): 277.
27. Schnabl B. Linking intestinal homeostasis and liver disease[J]. Curr Opin Gastroenterol, 2013, 29 (3): 264-270.
28. Mangell P, Nejdfors P, Wang M, et al. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal perme-ability[J]. Dig Dis Sci, 2002, 47 (3): 511-516.
29. Chiva M, Soriano G, Rochat I, et al. Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis[J]. J Hepatol, 2002, 37 (4): 456-462.
30. Shukla S, Shukla A, Mehboob S, et al. Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy[J]. Aliment Pharmacol Ther, 2011, 33 (6): 662-671.